info@seagull-health.com
SeagullHealth
语言:
search
new
Indications of Loteprednol Etabonate Suspension Eye Drops (Lotemax)
502
Article source: Seagull Pharmacy
Sep 17, 2025

Loteprednol Etabonate Suspension Eye Drops (Lotemax) is a glucocorticoid ophthalmic preparation, mainly used for the treatment of ocular inflammatory diseases.

Indications of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Core Applicable Diseases

Loteprednol Etabonate Suspension Eye Drops is suitable for the short-term treatment of the following ocular inflammatory diseases:

Postoperative inflammation: Inflammatory reactions caused by surgeries such as cataract surgery.

Allergic conjunctivitis: Relieves symptoms such as hyperemia and pruritus of the eyelids and conjunctiva caused by exposure to allergens.

Non-infectious keratitis: Including non-infectious corneal lesions such as superficial punctate keratitis.

Action Characteristics

As a topical glucocorticoid, its anti-inflammatory effect is stronger than that of hydrocortisone, while it has less systemic absorption and higher efficacy.

Specifications and Properties of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Dosage Form and Concentration

Dosage form: White suspension eye drops, which need to be shaken well before use.

Specification: Commonly available as 5ml per bottle, containing 0.5% loteprednol etabonate (5mg/ml).

Composition

Active ingredient: Loteprednol Etabonate.

Excipients: Including glycerin, polysorbate 80, boric acid, etc. The pH value is approximately 7.0-8.0.

Physical properties: The suspension may separate into layers when left standing, and will return to a uniform state after being shaken well.

Usage

Instillation frequency: Usually 3-4 times a day, 1-2 drops each time; follow the doctor's advice for specific usage.

Precautions: Avoid the tip of the dropper touching the eyes or skin to prevent contamination of the liquid medicine.

Storage Method of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Environmental Requirements

Temperature: It is recommended to store at 15°C to 25°C (59°F to 77°F), and freezing should be avoided.

Light and moisture protection: Store in the original packaging to prevent direct light exposure and humid environments.

Expiration Date and Packaging

Expiration date after opening: Usually 4 weeks; any unused medicine beyond this period should be discarded.

Packaging integrity: Check the tightness of the bottle cap. If leakage or abnormalities of the suspension (such as discoloration, sedimentation) are found, the product should be discontinued.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Precautions for Using Loteprednol Etabonate Suspension Eye Drops (Lotemax)
Loteprednol Etabonate Suspension Eye Drops (Lotemax) is a glucocorticoid ophthalmic preparation, mainly used for the treatment of ocular inflammatory diseases. As a topically applied corticosteroid, i...
How Effective is Loteprednol Suspension Eye Drops (Lotemax)?
Loteprednol Suspension Eye Drops (Lotemax) is a commonly used ophthalmic corticosteroid drug that plays an important role in the treatment of various ocular inflammatory diseases.How Effective is Lote...
What are the Side Effects of Loteprednol Etabonate Suspension Eye Drops (Lotemax)?
Loteprednol Etabonate Suspension Eye Drops (Lotemax) is a topically administered glucocorticoid medication, primarily used to treat ocular inflammatory conditions such as allergic conjunctivitis and p...
Precautions for Administration of Revuforj
Revuforj is a targeted menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia with KMT2A gene translocation. As an innovative targeted drug, its unique mechanism of actio...
Indications of Emicizumab
Emicizumab is a revolutionary humanized bispecific monoclonal antibody that mimics the function of coagulation factor VIII by bridging activated coagulation factors IX and X.Indications of EmicizumabM...
How Effective is Emicizumab in Treatment?
As an innovative therapeutic agent, Emicizumab has demonstrated considerable value in the field of hemophilia A treatment in recent years.How Effective is Emicizumab in Treatment?Bleeding Prevention E...
Indications of Cemiplimab
Cemiplimab is a programmed death receptor-1 (PD-1) blocking antibody that activates the immune system to fight against tumors by inhibiting the PD-1/PD-L1 pathway.Indications of CemiplimabCore Indicat...
How to Use Cemiplimab
Cemiplimab is a monoclonal antibody targeting PD-1, indicated for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) that cannot be cured by surgery or radiothera...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved